Genmab A/SGMABNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+17.8%
5Y CAGR+18.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+17.8%/yr
vs +48.0%/yr prior
5Y CAGR
+18.6%/yr
Consistent
Acceleration
-30.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$23.73B+10.2%
2024$21.53B+30.7%
2023$16.47B+13.6%
2022$14.51B+72.3%
2021$8.42B-16.8%
2020$10.11B+88.4%
2019$5.37B+77.4%
2018$3.03B+27.9%
2017$2.37B+30.2%
2016$1.82B-